Literature DB >> 10428079

Astroglia contain a specific transport mechanism for N-acetyl-L-aspartate.

T N Sager1, C Thomsen, J S Valsborg, H Laursen, A J Hansen.   

Abstract

N-Acetylaspartate (NAA) is the second most abundant amino acid in the adult brain. It is located and synthesized in neurons and probably degraded in the glia compartment, but the transport mechanisms are unknown. Rat primary neuron and astrocyte cell cultures were exposed to the L isomer of [3H]NAA and demonstrated concentration-dependent uptake of [3H]NAA with a Km approximately 80 microM. However, Vmax was 23+/-6.4 pmol/mg of protein/min in astrocytes but only 1.13+/-0.4 pmol/mg of protein/min in neurons. The fact that neuron cultures contain 3-5% astrocytes suggests that the uptake mechanism is expressed only in glial cells. The astrocyte uptake was temperature and sodium chloride dependent and specific for L-NAA. The affinity for structural analogues was (IC50 in mM) as follows: L-NAA (0.12) > N-acetylaspartylglutamate (0.4) > N-acetylglutamate (0.42) > L-aspartate (>1) > L-glutamate (>1) > or = DL-threo-beta-hydroxyaspartate > N-acetyl-L-histidine. The naturally occurring amino acids showed no inhibitory effect at 1 mM. The glutamate transport blocker trans-pyrrolidine-2,4-dicarboxylate exhibited an IC50 of 0.57 mM, whereas another specific glutamate transport inhibitor, DL-threo-beta-hydroxyaspartate, had an IC50 of >1 mM. The experiments suggest that NAA transport in brain parenchyma occurs by a novel type of sodium-dependent carrier that is present only in glial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428079     DOI: 10.1046/j.1471-4159.1999.0730807.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

2.  Structure of aspartoacylase, the brain enzyme impaired in Canavan disease.

Authors:  Eduard Bitto; Craig A Bingman; Gary E Wesenberg; Jason G McCoy; George N Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

3.  Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.

Authors:  Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

Review 4.  N-acetylaspartate in the vertebrate brain: metabolism and function.

Authors:  Morris H Baslow
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

Review 5.  Neuroimaging research in human MDMA users: a review.

Authors:  Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2006-07-18       Impact factor: 4.530

6.  Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users.

Authors:  Ronald L Cowan; Nicolas R Bolo; Mary Dietrich; Erica Haga; Scott E Lukas; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2007-06-18       Impact factor: 3.222

7.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

8.  Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility.

Authors:  Sankar Surendran
Journal:  Mol Biol Rep       Date:  2007-10-18       Impact factor: 2.316

Review 9.  Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation.

Authors:  Morris H Baslow
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 10.  Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.

Authors:  M H Baslow
Journal:  J Mol Neurosci       Date:  2000-10       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.